Acute limb ischemia and outcomes with vorapaxar in patients with peripheral artery disease

Circulation

Volumn 133, Issue 10, 2016, Pages 997-1005

  Bonaca, Marc P ^a   Gutierrez, J Antonio ^a   Creager, Mark A ^b   Scirica, Benjamin M ^a   Olin, Jeffrey ^c   Murphy, Sabina A ^a   Braunwald, Eugene ^a   Morrow, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

limb; limb ischemia; peripheral artery disease; peripheral vascular diseases; thrombosis

Indexed keywords

VORAPAXAR; ANTITHROMBOCYTIC AGENT; LACTONE; PYRIDINE DERIVATIVE;

ACUTE DISEASE; ADULT; AGED; AMPUTATION; ANGIOPLASTY; ANKLE BRACHIAL INDEX; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; FEMALE; FOLLOW UP; HUMAN; IN SITU THROMBOSIS; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVASCULARIZATION; SECONDARY PREVENTION; SMOKING; STENT; STENT THROMBOSIS; SURGICAL GRAFT THROMBOSIS; THROMBOEMBOLISM; THROMBOSIS; TREATMENT OUTCOME; ADVERSE EFFECTS; ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; FIBRINOLYTIC THERAPY; ISCHEMIA; LIMB; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDY; STROKE; VASCULARIZATION;

ACUTE DISEASE; AGED; ATHEROSCLEROSIS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; LACTONES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; PYRIDINES; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84960510232     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.019355     Document Type: Article

References (33)

1. Criqui MH, Peripheral arterial disease: epidemiological aspects. Vasc Med 2001 6 suppl 3 7
2. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D, Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992 326 381 386. doi: 10.1056/NEJM199202063260605
3. Fowkes FG, Murray GD, Butcher I, Folsom AR, Hirsch AT, Couper DJ, Debacker G, Kornitzer M, Newman AB, Sutton-Tyrrell KC, Cushman M, Lee AJ, Price JF, D?Agostino RB Sr, Murabito JM, Norman P, Masaki KH, Bouter LM, Heine RJ, Stehouwer CD, McDermott MM, Stoffers HE, Knottnerus JA, Ogren M, Hedblad B, Koenig W, Meisinger C, Cauley JA, Franco O, Hunink MG, Hofman A, Witteman JC, Criqui MH, Langer RD, Hiatt WR, Hamman RF, Ankle Brachial Index Collaboration Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur J Prev Cardiol 2014 21 310 320. doi: 10.1177/2047487313516564
4. Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM, Wilson PW, Alberts MJ, D?Agostino R, Liau CS, Mas JL, Röther J, Smith SC Jr, Salette G, Contant CF, Massaro JM, Steg PG, REACH Registry Investigators Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 2010 304 1350 1357. doi: 10.1001/jama.2010.1322
5. Steg PG, Bhatt DL, Wilson PW, D?Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S, REACH Registry Investigators One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007 297 1197 1206. doi: 10.1001/jama.297.11.1197
6. Hirsch AT, Duval S, The global pandemic of peripheral artery disease. Lancet 2013 382 1312 1314. doi: 10.1016/S0140-6736(13)61576-7
7. CAPRIE Investigators A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE): CAPRIE Steering Committee. Lancet 1996 348 1329 1339
8. Antithrombotic Trialists? Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 324 71 86
9. Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, Lee R, Bancroft J, MacEwan S, Shepherd J, Macfarlane P, Morris A, Jung R, Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese G, McKnight J, O?Brien I, Semple C, Petrie J, Gordon D, Pringle S, MacWalter R, Prevention of Progression of Arterial Disease and Diabetes Study Group; Diabetes Registry Group; Royal College of Physicians Edinburgh The Prevention of Progression of Arterial Disease and Diabetes (POPADAD) Trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008 337 a1840
10. Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KA, CHARISMA Investigators Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 2007 49 1982 1988. doi: 10.1016/j.jacc.2007.03.025
11. Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC, Sandercock PA, Fox KA, Lowe GD, Murray GD, Aspirin for Asymptomatic Atherosclerosis Trialists Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 2010 303 841 848. doi: 10.1001/jama.2010.221
12. Warfarin Antiplatelet Vascular Evaluation Trial Investigators Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G, Warfarin Antiplatelet Vascular Evaluation Trial Investigators Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 2007 357 217 227
13. Bonaca MP, Creager MA, Pharmacological treatment and current management of peripheral artery disease. Circ Res 2015 116 1579 1598. doi: 10.1161/CIRCRESAHA.114.303505
14. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, Golzarian J, Gornik HL, Halperin JL, Jaff MR, Moneta GL, Olin JW, Stanley JC, White CJ, White JV, Zierler RE, Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011 58 2020 2045. doi: 10.1016/j.jacc.2011.08.023
15. Mahoney EM, Wang K, Keo HH, Duval S, Smolderen KG, Cohen DJ, Steg G, Bhatt DL, Hirsch AT, Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes 2010 3 642 651. doi: 10.1161/CIRCOUTCOMES.109.930735
16. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Goto S, Ohman EM, Elbez Y, Sritara P, Baumgartner I, Banerjee S, Creager MA, Bhatt DL, REACH Registry Investigators Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J 2014 35 2864 2872. doi: 10.1093/eurheartj/ehu080
17. Creager MA, Kaufman JA, Conte MS, Clinical practice: acute limb ischemia. N Engl J Med 2012 366 2198 2206. doi: 10.1056/NEJMcp1006054
18. Duval S, Keo HH, Oldenburg NC, Baumgartner I, Jaff MR, Peacock JM, Tretinyak AS, Henry TD, Luepker RV, Hirsch AT, The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: the FRIENDS registry. Am Heart J 2014 168 577 587. doi: 10.1016/j.ahj.2014.06.013
19. Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA, TRA 2P-TIMI 50 Steering Committee and Investigators Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med 2012 366 1404 1413. doi: 10.1056/NEJMoa1200933
20. Magnani G, Bonaca MP, Braunwald E, Dalby AJ, Fox KA, Murphy SA, Nicolau JC, Oude Ophuis T, Scirica BM, Spinar J, Theroux P, Morrow DA, Efficacy and safety of vorapaxar as approved for clinical use in the United States. J Am Heart Assoc 2015 4 e001505. doi: 10.1161/JAHA.114.001505
21. Bonaca MP, Scirica BM, Creager MA, Olin J, Bounameaux H, Dellborg M, Lamp JM, Murphy SA, Braunwald E, Morrow DA, Vorapaxar in patients with peripheral artery disease: results from TRA2°P-TIMI 50. Circulation 2013 127 1522 1529, 1529e1. doi: 10.1161/CIRCULATIONAHA.112.000679
22. Morrow DA, Scirica BM, Fox KA, Berman G, Strony J, Veltri E, Bonaca MP, Fish P, McCabe CH, Braunwald E, TRA 2(o)P-TIMI 50 Investigators Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial. Am Heart J 2009 158 335 341.e3. doi: 10.1016/j.ahj.2009.06.027
23. Morrow DA, Scirica BM, Fox KA, Berman G, Strony J, Veltri E, Bonaca MP, Fish P, McCabe CH, Braunwald E, TRA 2(o)P-TIMI 50 Investigators Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial. Am Heart J 2009 158 335 341.e3. doi: 10.1016/j.ahj.2009.06.027
24. Ankle Brachial Index Collaboration Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d?Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodriguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM, Ankle Brachial Index Collaboration Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008 300 197 208
25. Conen D, Everett BM, Kurth T, Creager MA, Buring JE, Ridker PM, Pradhan AD, Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort study. Ann Intern Med 2011 154 719 726. doi: 10.7326/0003-4819-154-11-201106070-00003
26. Duval S, Keo HH, Oldenburg NC, Baumgartner I, Jaff MR, Peacock JM, Tretinyak AS, Henry TD, Luepker RV, Hirsch AT, The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: the FRIENDS registry. Am Heart J 2014 168 577 587. doi: 10.1016/j.ahj.2014.06.013
27. Henke PK, Contemporary management of acute limb ischemia: factors associated with amputation and in-hospital mortality. Semin Vasc Surg 2009 22 34 40. doi: 10.1053/j.semvascsurg.2009.01.002
28. Kropman RH, Schrijver AM, Kelder JC, Moll FL, de Vries JP, Clinical outcome of acute leg ischaemia due to thrombosed popliteal artery aneurysm: systematic review of 895 cases. Eur J Vasc Endovasc Surg 2010 39 452 457. doi: 10.1016/j.ejvs.2009.11.010
29. Campbell WB, Marriott S, Eve R, Mapson E, Sexton S, Thompson JF, Amputation for acute ischaemia is associated with increased comorbidity and higher amputation level. Cardiovasc Surg 2003 11 121 123
30. Belch JJ, Dormandy J, Biasi GM, Biasi BM, Cairols M, Diehm C, Eikelboom B, Golledge J, Jawien A, Lepäntalo M, Norgren L, Hiatt WR, Becquemin JP, Bergqvist D, Clement D, Baumgartner I, Minar E, Stonebridge P, Vermassen F, Matyas L, Leizorovicz A, CASPAR Writing Committee Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 2010 52 825 33, 833.e1. doi: 10.1016/j.jvs.2010.04.027
31. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 2000 355 346 351
32. AstraZeneca. A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID)-NCT01732822. www.clinicaltrials.gov. Accessed July 9, 2014
33. Bayer. Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)-NCT01776424. www.clinicaltrials.gov. Accessed July 9. 2014